Pharma-Bio Serv (PBSV) to Release Earnings on Wednesday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to be issuing its results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $0.03 per share for the quarter.

Pharma-Bio Serv Stock Performance

Shares of Pharma-Bio Serv stock opened at $0.54 on Wednesday. The firm has a fifty day moving average of $0.55 and a two-hundred day moving average of $0.58. The stock has a market capitalization of $12.49 million, a price-to-earnings ratio of -54.45 and a beta of 0.73. Pharma-Bio Serv has a 52 week low of $0.35 and a 52 week high of $1.36.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.